Global Disruptive Behavior Disorders (DBD) Market Size, Status and Forecast 2019-2025

Description

Disruptive Behavior Disorders (DBD) is behavioral disorders characterized by hostile and defiant behaviors that children and adolescents direct towards others.
The global disruptive behavior disorders market is being driven by the rise in the number of comorbid disorders, active involvement of NGO and government programs to increase awareness.
In 2018, the global Disruptive Behavior Disorders (DBD) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Disruptive Behavior Disorders (DBD) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Disruptive Behavior Disorders (DBD) development in United States, Europe and China.

The key players covered in this study
Eli Lilly
Bionomics
Chelsea Therapeutics
Pfizer
Johnson & Johnson
DURECT
Novartis
McNeil Pharmaceuticals
Sunovion Pharmaceuticals
New River Pharmaceuticals

Market segment by Type, the product can be split into
Conduct Disorder (CD)
Oppositional Defiant Disorder (ODD)

Market segment by Application, split into
Hospitals and Clinics
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Disruptive Behavior Disorders (DBD) status, future forecast, growth opportunity, key market and key players.
To present the Disruptive Behavior Disorders (DBD) development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Disruptive Behavior Disorders (DBD) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

TABLE OF CONTENT

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Disruptive Behavior Disorders (DBD) Market Size Growth Rate by Type (2014-2025)
1.4.2 Conduct Disorder (CD)
1.4.3 Oppositional Defiant Disorder (ODD)
1.5 Market by Application
1.5.1 Global Disruptive Behavior Disorders (DBD) Market Share by Application (2014-2025)
1.5.2 Hospitals and Clinics
1.5.3 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Disruptive Behavior Disorders (DBD) Market Size
2.2 Disruptive Behavior Disorders (DBD) Growth Trends by Regions
2.2.1 Disruptive Behavior Disorders (DBD) Market Size by Regions (2014-2025)
2.2.2 Disruptive Behavior Disorders (DBD) Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Disruptive Behavior Disorders (DBD) Market Size by Manufacturers
3.1.1 Global Disruptive Behavior Disorders (DBD) Revenue by Manufacturers (2014-2019)
3.1.2 Global Disruptive Behavior Disorders (DBD) Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Disruptive Behavior Disorders (DBD) Market Concentration Ratio (CR5 and HHI)
3.2 Disruptive Behavior Disorders (DBD) Key Players Head office and Area Served
3.3 Key Players Disruptive Behavior Disorders (DBD) Product/Solution/Service
3.4 Date of Enter into Disruptive Behavior Disorders (DBD) Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Disruptive Behavior Disorders (DBD) Market Size by Type (2014-2019)
4.2 Global Disruptive Behavior Disorders (DBD) Market Size by Application (2014-2019)

5 United States
5.1 United States Disruptive Behavior Disorders (DBD) Market Size (2014-2019)
5.2 Disruptive Behavior Disorders (DBD) Key Players in United States
5.3 United States Disruptive Behavior Disorders (DBD) Market Size by Type
5.4 United States Disruptive Behavior Disorders (DBD) Market Size by Application

6 Europe
6.1 Europe Disruptive Behavior Disorders (DBD) Market Size (2014-2019)
6.2 Disruptive Behavior Disorders (DBD) Key Players in Europe
6.3 Europe Disruptive Behavior Disorders (DBD) Market Size by Type
6.4 Europe Disruptive Behavior Disorders (DBD) Market Size by Application

7 China
7.1 China Disruptive Behavior Disorders (DBD) Market Size (2014-2019)
7.2 Disruptive Behavior Disorders (DBD) Key Players in China
7.3 China Disruptive Behavior Disorders (DBD) Market Size by Type
7.4 China Disruptive Behavior Disorders (DBD) Market Size by Application

8 Japan
8.1 Japan Disruptive Behavior Disorders (DBD) Market Size (2014-2019)
8.2 Disruptive Behavior Disorders (DBD) Key Players in Japan
8.3 Japan Disruptive Behavior Disorders (DBD) Market Size by Type
8.4 Japan Disruptive Behavior Disorders (DBD) Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Disruptive Behavior Disorders (DBD) Market Size (2014-2019)
9.2 Disruptive Behavior Disorders (DBD) Key Players in Southeast Asia
9.3 Southeast Asia Disruptive Behavior Disorders (DBD) Market Size by Type
9.4 Southeast Asia Disruptive Behavior Disorders (DBD) Market Size by Application

10 India
10.1 India Disruptive Behavior Disorders (DBD) Market Size (2014-2019)
10.2 Disruptive Behavior Disorders (DBD) Key Players in India
10.3 India Disruptive Behavior Disorders (DBD) Market Size by Type
10.4 India Disruptive Behavior Disorders (DBD) Market Size by Application

11 Central & South America
11.1 Central & South America Disruptive Behavior Disorders (DBD) Market Size (2014-2019)
11.2 Disruptive Behavior Disorders (DBD) Key Players in Central & South America
11.3 Central & South America Disruptive Behavior Disorders (DBD) Market Size by Type
11.4 Central & South America Disruptive Behavior Disorders (DBD) Market Size by Application

12 International Players Profiles
12.1 Eli Lilly
12.1.1 Eli Lilly Company Details
12.1.2 Company Description and Business Overview
12.1.3 Disruptive Behavior Disorders (DBD) Introduction
12.1.4 Eli Lilly Revenue in Disruptive Behavior Disorders (DBD) Business (2014-2019)
12.1.5 Eli Lilly Recent Development
12.2 Bionomics
12.2.1 Bionomics Company Details
12.2.2 Company Description and Business Overview
12.2.3 Disruptive Behavior Disorders (DBD) Introduction
12.2.4 Bionomics Revenue in Disruptive Behavior Disorders (DBD) Business (2014-2019)
12.2.5 Bionomics Recent Development
12.3 Chelsea Therapeutics
12.3.1 Chelsea Therapeutics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Disruptive Behavior Disorders (DBD) Introduction
12.3.4 Chelsea Therapeutics Revenue in Disruptive Behavior Disorders (DBD) Business (2014-2019)
12.3.5 Chelsea Therapeutics Recent Development
12.4 Pfizer
12.4.1 Pfizer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Disruptive Behavior Disorders (DBD) Introduction
12.4.4 Pfizer Revenue in Disruptive Behavior Disorders (DBD) Business (2014-2019)
12.4.5 Pfizer Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Company Details
12.5.2 Company Description and Business Overview
12.5.3 Disruptive Behavior Disorders (DBD) Introduction
12.5.4 Johnson & Johnson Revenue in Disruptive Behavior Disorders (DBD) Business (2014-2019)
12.5.5 Johnson & Johnson Recent Development
12.6 DURECT
12.6.1 DURECT Company Details
12.6.2 Company Description and Business Overview
12.6.3 Disruptive Behavior Disorders (DBD) Introduction
12.6.4 DURECT Revenue in Disruptive Behavior Disorders (DBD) Business (2014-2019)
12.6.5 DURECT Recent Development
12.7 Novartis
12.7.1 Novartis Company Details
12.7.2 Company Description and Business Overview
12.7.3 Disruptive Behavior Disorders (DBD) Introduction
12.7.4 Novartis Revenue in Disruptive Behavior Disorders (DBD) Business (2014-2019)
12.7.5 Novartis Recent Development
12.8 McNeil Pharmaceuticals
12.8.1 McNeil Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Disruptive Behavior Disorders (DBD) Introduction
12.8.4 McNeil Pharmaceuticals Revenue in Disruptive Behavior Disorders (DBD) Business (2014-2019)
12.8.5 McNeil Pharmaceuticals Recent Development
12.9 Sunovion Pharmaceuticals
12.9.1 Sunovion Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Disruptive Behavior Disorders (DBD) Introduction
12.9.4 Sunovion Pharmaceuticals Revenue in Disruptive Behavior Disorders (DBD) Business (2014-2019)
12.9.5 Sunovion Pharmaceuticals Recent Development
12.10 New River Pharmaceuticals
12.10.1 New River Pharmaceuticals Company Details
12.10.2 Company Description and Business Overview
12.10.3 Disruptive Behavior Disorders (DBD) Introduction
12.10.4 New River Pharmaceuticals Revenue in Disruptive Behavior Disorders (DBD) Business (2014-2019)
12.10.5 New River Pharmaceuticals Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

Choose License Type

Checkout Inquiry Sample